Infusion Duration Study To Assess Tolerability of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
Public ClinicalTrials.gov record NCT04511702. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 4, Multicenter, Open-Label, Infusion Duration Study To Assess Safety, Tolerability and Efficacy of Pegloticase Administered With a Shorter Infusion Duration in Subjects With Uncontrolled Gout Receiving Methotrexate
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to assess the safety, tolerability and efficiency of pegloticase administered with a shorter infusion duration in participants with uncontrolled gout receiving methotrexate.
Study identification
- NCT ID
- NCT04511702
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 191 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2, 2020 (Actual)
- Primary completion
- Jan 18, 2024 (Actual)
- Completion
- Mar 25, 2024 (Actual)
- Last update posted
- Oct 20, 2025
2020 – 2024
United States locations
- U.S. sites
- 39
- U.S. states
- 17
- U.S. cities
- 36
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Orthopedic Physicians Alaska | Anchorage | Alaska | 99508 | — |
| Arizona Arthritis & Rheumatology Research | Gilbert | Arizona | 85297 | — |
| Arthritis & Rheumatology Research | Mesa | Arizona | 85210 | — |
| Arizona Arthritis & Rheumatology Research | Phoenix | Arizona | 85037 | — |
| Medvin Clinical Research | Covina | California | 91722 | — |
| Amicis Research Center | Northridge | California | 91324 | — |
| Providence Saint John's Health Center | Santa Monica | California | 90404 | — |
| Medvin Clinical Research | Thousand Oaks | California | 91360 | — |
| Medvin Clinical Research | Tujunga | California | 91042 | — |
| University of Colorado Division of Rheumatology | Aurora | Colorado | 80045 | — |
| Denver Arthritis Clinic | Denver | Colorado | 80230 | — |
| Bradenton Research Center | Bradenton | Florida | 34205 | — |
| Prohealth Research Center | Doral | Florida | 33166 | — |
| LIFE Clinical Trials | Margate | Florida | 33063 | — |
| D&H National Research Centers | Miami | Florida | 33155 | — |
| IRIS Research and Development, LLC | Plantation | Florida | 33324 | — |
| Napa Research Center | Pompano Beach | Florida | 33064 | — |
| D&H Tamarac Research Centers | Tamarac | Florida | 33321 | — |
| GCP Clinical Research | Tampa | Florida | 33064 | — |
| ClinPro Research Solutions | Tampa | Florida | 33609 | — |
| ForCare Clinical Research | Tampa | Florida | 33613 | — |
| MedPharmics, LLC | Metairie | Louisiana | 70006 | — |
| MD Medical Research | Oxon Hill | Maryland | 20745 | — |
| Santa Fe Rheumatology | Santa Fe | New Mexico | 87505 | — |
| Long Island Arthritis & Osteoporosis Care | Babylon | New York | 11702 | — |
| Research Carolina Elite | Denver | North Carolina | 28037 | — |
| PMG Research of Hickory, LLC | Hickory | North Carolina | 28602 | — |
| Cape Fear Arthritis Care | Leland | North Carolina | 28451 | — |
| PMG Research of Salisbury, LLC | Salisbury | North Carolina | 28144 | — |
| Shelby Clinical Research, LLC | Shelby | North Carolina | 28150 | — |
| Velocity Clinical Research Cincinnati | Cincinnati | Ohio | 45242 | — |
| Altoona Center for Clinical Research | Duncansville | Pennsylvania | 16635 | — |
| Chattanooga Research & Medicine PLLC (CHARM) | Chattanooga | Tennessee | 37404 | — |
| Abigail Rebecca Neiman, MD, PA | Houston | Texas | 77024 | — |
| Pioneer Research Solutions Inc - Houston | Houston | Texas | 77099 | — |
| Velocity Clinical Research, Salt Lake City | West Jordan | Utah | 84088 | — |
| Western Washington Medical Group | Bothell | Washington | 98021 | — |
| Arthritis Northwest | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04511702, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 20, 2025 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04511702 live on ClinicalTrials.gov.